
Gilead Sciences (GILD), CONMED Corp (CNMD), and Thermo Fisher Scientific (TMO) will trade ex-dividend on 6/13/25, with respective dividend payments of $0.79, $0.20, and $0.43. This translates to an expected price decrease at market open on 6/13/25 of 0.72% for GILD, 0.34% for CNMD, and 0.10% for TMO, all else being equal; if dividends continue at their current rate, the estimated annual yields would be 2.87% for GILD, 1.35% for CNMD, and 0.41% for TMO.
Gilead Sciences Inc (GILD), CONMED Corp (CNMD), and Thermo Fisher Scientific Inc (TMO) are set to trade ex-dividend on June 13, 2025, with respective quarterly dividend payments of $0.79, $0.20, and $0.43. This event is anticipated to result in a mechanical price reduction at market open on the ex-dividend date: approximately 0.72% for GILD (based on its recent $110.09 price), 0.34% for CNMD, and 0.10% for TMO, assuming all other market conditions remain stable. If these dividend payouts are maintained, the estimated annualized yields would be 2.87% for Gilead Sciences, 1.35% for CONMED Corp, and 0.41% for Thermo Fisher Scientific. The article highlights that dividend predictability is tied to company profitability, suggesting that an examination of historical dividend stability is a prudent step for investors. In recent trading, GILD shares experienced a decline of about 2.6%, contrasting with CNMD's approximate 0.6% gain and TMO's 1.5% rise. This market activity aligns with per-ticker sentiment scores, which indicate a slightly negative sentiment for GILD (-0.2) and slightly positive sentiment for CNMD (0.1) and TMO (0.2), within an overall neutral sentiment context for the news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment